LONDON — Policymakers and scientific groups need to specify guidelines for the burgeoning field that uses stem cells to mimic ...

Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

Bhattacharya would be in charge of Trump's bold goals to reform the NIH, which spends billions to fund medical research.

Opinion: Low pay, high pressure, a troubling political landscape — it’s all leading to medical students electing not to ...

President-elect Trump has nominated biotech investor Jim O’Neill for deputy secretary of the Health and Human Services ...

I spent four crazy years writing about Cassava Sciences, Adam Feuerstein writes. Yesterday, the story ended exactly as many ...

Health officials in British Columbia, Canada, have failed, for now, to confirm how a teenager there became infected with H5N1 ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

The U.S. life sciences community is bracing for the return of travel restrictions in the second Trump administration.

The law is intended to crack down on Chinese biotech companies, but it may become more difficult to pass next year.

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.